<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02932501</url>
  </required_header>
  <id_info>
    <org_study_id>RP_MRONJ_1.0</org_study_id>
    <nct_id>NCT02932501</nct_id>
  </id_info>
  <brief_title>Medication-related Osteonecrosis of the Jaw (MRONJ) Registry</brief_title>
  <acronym>MRONJ</acronym>
  <official_title>International, Multicenter, Prospective Registry to Collect Data of Treatment Patterns of Patients With Medication-related Osteonecrosis of the Jaw (MRONJ) and Their Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AO Clinical Investigation and Documentation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AO CMF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AO Clinical Investigation and Documentation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 500 patients will be included in this patient registry. Data collection
      includes demographics, clinical data of underlying disease and use of bisphosphonates,
      denosumab and antiangiogenic drugs , degree and extension of osteonecrosis,
      osteonecrosis-specific treatment, outcomes and complications within 1 year after treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 500 patients diagnosed with medication-related osteonecrosis of the jaw will be
      enrolled in the study. Patients will undergo standard (routine) of care treatment, either
      conservative or surgical or both, and followed up during one year after the initiation of the
      treatment. Treatment outcome (development of the condition), pain and complications will be
      collected and documented over the duration of the registry.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2017</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Treatment outcome</measure>
    <time_frame>6 months / 1 year</time_frame>
    <description>Compared to the baseline status of the patient's condition, the outcome will be evaluated as:
Worsening of the osteonecrosis (e.g. size of the lesion increased)
No change of the osteonecrosis
Reduction of the osteonecrosis (e.g. size of the lesion decrease)
Complete mucosa healing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>6 months / 1 year</time_frame>
    <description>Numeric Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Staging of osteonecrosis</measure>
    <time_frame>6 months / 1 year</time_frame>
    <description>Staging of osteonecrosis according to the American Association of Oral and Maxillofacial Surgeons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Site and size of the lesion</measure>
    <time_frame>6 months / 1 year</time_frame>
    <description>Site (single vs. multiple) and size of the lesion according to Weitzman et al.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Medication-related Osteonecrosis of the Jaw</condition>
  <condition>Bisphosphonate-Associated Osteonecrosis of the Jaw</condition>
  <arm_group>
    <arm_group_label>MRONJ</arm_group_label>
    <description>Patients diagnosed of medication-related osteonecrosis of the jaw (MRONJ). Treatment strategies vary depending on the stage of MRONJ and can be of different nature as:
Conservative treatment Surgical treatment Adjuvant non-surgical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conservative treatment</intervention_name>
    <description>Disinfectant mouth rinses, Antibiotic therapy, Antifungal therapy</description>
    <arm_group_label>MRONJ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical treatment</intervention_name>
    <description>Superficial debridement, Complete removal of necrotic bone, Complete bone resection, When applicable revision and soft tissue coverage</description>
    <arm_group_label>MRONJ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adjuvant non-surgical treatment</intervention_name>
    <description>Hyperbaric oxygen therapy Pentoxifylline and tocopherol Ozone therapy Low level laser therapy Pain relief Anti-inflammatory treatment Platelet rich plasma Parathyroid hormone and teriparatide Bone morphogenetic protein</description>
    <arm_group_label>MRONJ</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed of medication-related osteonecrosis of the jaw (MRONJ)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Newly diagnosed patients with osteonecrosis in a facial bone other than the jaw, or

          -  Newly diagnosed patients with non-exposed MRONJ (stage 0), or

          -  Newly diagnosed patients with exposed MRONJ, i.e:

               -  Current or previous treatment with antiresorptive or antiangiogenic agents.

               -  Exposed bone or bone that can be probed through an intraoral or extraoral
                  fistula(e) in the maxillofacial region that has persisted for more than 8 weeks

               -  No history of radiation therapy to the jaws or obvious metastatic diseases of the
                  jaw

          -  Ability to understand the content of the patient information/ Informed Consent Form

          -  Willingness and ability to participate in the clinical investigation according to the
             Registry Plan (RP)

          -  Signed and dated IRB/EC-approved written informed consent

          -  Mental capacity to comply with post-operative regimen, evaluation and data collection

        Exclusion Criteria:

          -  Recent history of substance abuse (i. e., recreational drugs, alcohol) that would
             preclude reliable assessment

          -  Pregnancy or women planning to conceive within the registry period

          -  Prisoner

          -  Participation in any other medical device or medicinal product study within the
             previous month that could influence the results of the present registry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Risto Kontio, MD DDS PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Víctor Díaz, PhD</last_name>
    <phone>0041814142507</phone>
    <email>victor.diaz@aofoundation.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kentucky Chandler Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Larry Cunningham</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edward Ellis III</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Risto Kontio, MD DDS PhD</last_name>
      <phone>+358 9 47188212</phone>
      <email>risto.kontio@medius.fi</email>
    </contact>
    <investigator>
      <last_name>Risto Kontio, MD DDS PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Max Heiland</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätskliniken Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexandre Assaf</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ludwig-Maximilians University Munich, Klinik und Poliklinik für Mund-, Kiefer und Gesichtschirurgie</name>
      <address>
        <city>München</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven Otto, PD. Dr. Dr.</last_name>
      <phone>+49 89 4400 54475</phone>
      <email>Sven.Otto@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Sven Otto, PD. Dr. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyungpool National University</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tae-Geon KWON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eramus MC</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eppo Wolvius</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamad Medical Corporation</name>
      <address>
        <city>Doha</city>
        <country>Qatar</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Moustafa Alkhalil, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emergency Clinical County Hospital of Constanta</name>
      <address>
        <city>Constanta</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian Creanga, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dime Sapundzhiev</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>12 de Octubre University Hospital</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregorio Sanchez Ancieto</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital La Paz de Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miguel Burgueño</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Berg, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Luzerner Kantonsspital</name>
      <address>
        <city>Luzern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Della Chiesa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Zürich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Schumann</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Germany</country>
    <country>Korea, Republic of</country>
    <country>Netherlands</country>
    <country>Qatar</country>
    <country>Romania</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>December 5, 2017</last_update_submitted>
  <last_update_submitted_qc>December 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bisphosphonate</keyword>
  <keyword>Jaw</keyword>
  <keyword>Osteonecrosis</keyword>
  <keyword>Antiresorptive drugs</keyword>
  <keyword>Denosumab</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Bisphosphonate-Associated Osteonecrosis of the Jaw</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

